Successful treatment of ergotism with Iloprost: A case report

Angiology

Volumn 49, Issue 6, 1998, Pages 493-497

  Piquemal, R ^a   Emmerich, J ^b   Guilmot, J L ^a   Fiessinger, J N ^b  

^a CHU BRETONNEAU   (France)

^b BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOTAMINE DERIVATIVE; ILOPROST; PROSTACYCLIN DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; ERGOTISM; FEMALE; FEMORAL ARTERY; HUMAN; ILIAC ARTERY; INTRAVENOUS DRUG ADMINISTRATION; LEG ANGIOGRAPHY; LEG ISCHEMIA; MIGRAINE; ORAL DRUG ADMINISTRATION;

EID: 0031800562     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900612     Document Type: Article

References (18)

1. Schmidt R, Erasmi H, Walter M, et al: Ergotisme et ischemic des membres. Ann Cardiol Angeiol 41:489-495, 1992.
2. Magee R: St. Anthony's fire revisited: Vascular problems associated with migraine medication. Med J Aust 154:145-149, 1991.
3. Olin JW: Syndromes that mimic vasculitis. Curr Opinion Cardiol 6:768-774, 1991.
4. Rail TW: Ergot and the ergot alkaloïds. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics, ed. 8, ed by Goodman Gilman A, Rall TW, Nies AS, et al. New York: Pergamon, 1990, pp 939-947.
5. Keigley B, Vogelzang RL, Neiman HL, et al: Ergotism presenting as restenosis following angioplasty. Cardiovasc Intervent Radiol 10:21-23, 1987.
6. Baader W, Herman C, Johansen K: Le feu de Saint Antoine: guérison du vasospasme périphérique dû à l'ergotamine par la dilatation artérielle hydrostatique. Ann Chir Vasc 4:597-599, 1990.
7. Kermerer VF, Dagher FJ, Pais SO: Successful treatment of ergotism with nifedipine. Am J Roentgenol 143:333-334, 1984.
8. Carliner NH, Denune DP, Finch CS, et al: Sodium nitroprusside treatment of ergotamine-induced peripheral ischemia. JAMA 227:308-309, 1974.
9. Husum B, Metz P, Rasmussen JP: Nitroglycerin infusion for ergotism (letter). Lancet 2:794-795, 1979.
10. Shifrin E, Olschwang D, Perel A, et al: Reversal of ergotamine-induced arteriospasm by mechanical intraarterial dilatation. Lancet 13:1278-1279, 1980.
11. 1 for alleviating symptoms of ergot intoxication: A case report. Cardiovasc Intervent Radiol 7:28-30, 1984.
12. 1 infusion. Dtsch Med Wochenschr 118:1067-1071, 1993.
13. Edwards RJ, Fulde GWO, McGrath MA: Successful limb salvage with prostaglandin infusion: A review of ergotamine toxicity. Med J Aust 155:825-827, 1991.
14. Fiessinger JN, Schäfer M, for the TAO study: Trial of iloprost versus aspirin treatment for critical limb ischemia of thromboangiitis obliterans. Lancet 335: 555-557, 1990.
15. Dormandy J: Use of the prostacyclin analogue iloprost in the treatment of patients with critical limb ischemia. Therapie 46:319-322, 1991.
16. Kyle MV, Belcher G, Hazleman BL: Placebo controlled study showing therapeutic benefit of iloprost in the treatment of Raynaud's phenomenon. J Rheumatol 19:1403-1406, 1992.
17. Gomez-Sanchez MA, De La Calzada CS, Gomez-Pajuelo C, et al: Different hemodynamic responses between acute and chronic infusion of Iloprost (prostacyclin-stable analogue) in severe pulmonary hypertension. Am Rev Respir Dis 144:1404-1405, 1991.
18. Grant SM, Goa KL: Iloprost: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in peripheral vascular disease, myocardial ischemia and extracorporeal circulation procedures. Drugs 43:889-924, 1992.